HCA Healthcare (NYSE:HCA – Get Free Report) is anticipated to release its earnings data before the market opens on Friday, January 24th. Analysts expect HCA Healthcare to post earnings of $6.03 per share and revenue of $18,234,322.79 billion for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
HCA Healthcare Stock Up 1.0 %
Shares of HCA opened at $309.26 on Friday. HCA Healthcare has a 52 week low of $276.50 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market capitalization of $78.34 billion, a P/E ratio of 13.89, a P/E/G ratio of 1.03 and a beta of 1.64. The company has a 50-day simple moving average of $318.49 and a 200-day simple moving average of $353.11.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.
Insider Transactions at HCA Healthcare
Analysts Set New Price Targets
A number of research firms have weighed in on HCA. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Oppenheimer upped their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, TD Cowen cut their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $385.27.
Check Out Our Latest Analysis on HCA
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- What is the S&P 500 and How It is Distinct from Other Indexes
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What Are Trending Stocks? Trending Stocks Explained
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Which Wall Street Analysts are the Most Accurate?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.